Karyopharm Therapeutics reported $24.99M in Trade Debtors for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Trade Debtors Change
TG Therapeutics TGTX:US 903K 486K
Abbott ABT:US $ 7179M 692M
Abbvie ABBV:US $ 10733M 756M
Amgen AMGN:US $ 5077M 182M
Astrazeneca AZN:US 9.05B 1.26B
AstraZeneca AZN:LN 9.05B 1.26B
Avrobio Inc AVRO:US 2.84M 147K
Biocryst Pharmaceuticals BCRX:US $ 36.42M 7M
Bristol Myers Squibb BMY:US $ 8511M 858M
Eli Lilly And LLY:US $ 7805.7M 321.5M
Enanta Pharmaceuticals ENTA:US $ 47.46M 8.94M
Epizyme EPZM:US $ 5.9M 670K
GlaxoSmithKline GSK:LN 8.8B 451M
Karyopharm Therapeutics KPTI:US $ 24.99M 2.5M
Merk MRK:US $ 9828M 598M
Novartis NVS:US $ 8678M 395M
Novartis NOVN:VX 8.68B 395M
Takeda 4502:JP Y 724377M 31740M
Ultragenyx Pharmaceutical RARE:US $ 28.37M 0.06M
YTE INCY:US $ 562.34M 53.96M